stempeutics research
Stem Cell-Based Drug Granted Chinese Patent
The bone marrow-based drug is indicated for the treatment of critical limb ischemia, a common complication of diabetes.
The bone marrow-based drug is indicated for the treatment of critical limb ischemia, a common complication of diabetes.
